Adventitious agent safety of urine-derived medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/BWP/126802/2012
Effective from01/12/2015
KeywordsUrine-derived medicinal products, adventitious agents, investigational studies
DescriptionThis document considers various aspects of viral saefty of urine-derived medicinal products: it provides guidance in inactivation/removal of virus and its validation.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

In operation: 01/12/2015–present

Published: 29/05/2015

Published: 22/11/2013

Related content

How useful was this page?

Add your rating